Copyright
©The Author(s) 2015.
World J Gastroenterol. Sep 14, 2015; 21(34): 9966-9973
Published online Sep 14, 2015. doi: 10.3748/wjg.v21.i34.9966
Published online Sep 14, 2015. doi: 10.3748/wjg.v21.i34.9966
Table 5 Pre-treatment and post-treatment absolute neutrophil/lymphocyte/monocyte counts
| Pre-treatment value | Post-treatment value | P value | |
| All patients | |||
| Neutrophil (mean ± SD) | 4538.5 ± 200.4 | 2798.0 ± 190.0 | < 0.001 |
| Lymphocyte (mean ± SD) | 1664.3 ± 649.1 | 1610.5 ± 671.0 | 0.247 |
| Monocyte (mean ± SD) | 422.1 ± 19.0 | 471.7 ± 24.6 | 0.027 |
| Patients receiving chemotherapy based on oxaliplatin | |||
| Neutrophil (mean ± SD) | 4455.8 ± 1962.6 | 2791.7 ± 1859.9 | < 0.001 |
| Lymphocyte (mean ± SD) | 1694.9 ± 695.4 | 1639.2 ± 677.8 | 0.365 |
| Monocyte (mean ± SD) | 412.4 ± 181.0 | 457.3 ± 248.4 | 0.001 |
| Patients receiving chemotherapy based on irinotecan | |||
| Neutrophil (mean ± SD) | 4567.6 ± 1873.2 | 2879.4 ± 2007.3 | 0.038 |
| Lymphocyte (mean ± SD) | 1307.5 ± 440.8 | 1238.6 ± 342.1 | 0.394 |
| Monocyte (mean ± SD) | 466.9 ± 221.0 | 427.0 ± 134.2 | 0.174 |
- Citation: Shibutani M, Maeda K, Nagahara H, Ohtani H, Sakurai K, Yamazoe S, Kimura K, Toyokawa T, Amano R, Tanaka H, Muguruma K, Hirakawa K. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer. World J Gastroenterol 2015; 21(34): 9966-9973
- URL: https://www.wjgnet.com/1007-9327/full/v21/i34/9966.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i34.9966